Compartment-specific cAMP dysfunction in diabetic cardiomyopathy in hiPSC-derived cardiomyocytes: therapeutic potential of fibroblast growth factor 1

Cardiovascular Diabetology · Published 2026-07-30 · DOI 10.1186/s12933-026-03288-9

Free full text

Authors (24)

Kun Liu, Kazuki Osuka, Mengying Xu, Rhea Takhar, Neda Mohammadi, Adam Trevett, Jinyan Zhong, Ching-Wen Chang, Nan Wang, Xinyu Hu, Ruirui Dong, Shunan Zhang, YoonYoung Choi, Thamali Ayagama, Mingyu Li, Linna Zhou, Che-Mai Chang, Wan-Chen Huang, Wei-Chiao Chang, Neil Herring, Annika Winbo, Guoliang Hao, Jie Zhang, Dan Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liu, K., Osuka, K., Xu, M., et al. (2026). Compartment-specific cAMP dysfunction in diabetic cardiomyopathy in hiPSC-derived cardiomyocytes: therapeutic potential of fibroblast growth factor 1. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03288-9

Related articles

• Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · Cardiovascular Diabetology · 2026 · Same journal
• Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · Cardiovascular Diabetology · 2026 · Same journal
• Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · Cardiovascular Diabetology · 2026 · Same journal
• Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model · Cardiovascular Diabetology · 2026 · Same journal
• Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · Cardiovascular Diabetology · 2026 · Same journal
• STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · Cardiovascular Diabetology · 2026 · Same journal
• Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · Cardiovascular Diabetology · 2026 · Same journal
• Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study · Cardiovascular Diabetology · 2026 · Same journal
• Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies · Cardiovascular Diabetology · 2026 · Same journal
• Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis · Cardiovascular Diabetology · 2026 · Same journal